Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) dropped from Russell 3000 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +0.88% |
|
+3.14% | +9.52% |
Jul. 01 | Aclaris Therapeutics Insider Bought Shares Worth $1,742,075, According to a Recent SEC Filing | MT |
Jul. 01 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Microcap Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.52% | 81.24M | |
+16.59% | 44.87B | |
-10.62% | 37.8B | |
+40.49% | 37.61B | |
+29.92% | 31.32B | |
-9.78% | 27.4B | |
+12.34% | 26.32B | |
+41.53% | 14.07B | |
+31.49% | 12.5B | |
-7.40% | 11.23B |
- Stock Market
- Equities
- ACRS Stock
- News Aclaris Therapeutics, Inc.
- Aclaris Therapeutics, Inc.(NasdaqGS: ACRS) dropped from Russell 3000 Growth Index